MBII

Wisconsin Connections Academy Announces Open Enrollment for the 2024-25 School Year

Retrieved on: 
Thursday, February 15, 2024

APPLETON, Wis., Feb. 15, 2024 /PRNewswire-PRWeb/ -- Wisconsin Connections Academy, the tuition-free, full-time online school for students in 4K through 12th grade, invites Wisconsin families across the state to enroll for the 2024-25 school year. The open application period for the upcoming school year officially began on Monday, February 5 and closes Friday, April 30, 2024 at 4 p.m. Central. Families who wish to enroll outside their local school district can complete an Open Enrollment Application via the Wisconsin Department of Public Instruction.

Key Points: 
  • APPLETON, Wis., Feb. 15, 2024 /PRNewswire-PRWeb/ -- Wisconsin Connections Academy, the tuition-free, full-time online school for students in 4K through 12th grade, invites Wisconsin families across the state to enroll for the 2024-25 school year.
  • Families who wish to enroll outside their local school district can complete an Open Enrollment Application via the Wisconsin Department of Public Instruction .
  • "I've been with Wisconsin Connections Academy from the start in 2002 and I can proudly say that our students benefit from the unique aspects of online school.
  • Wisconsin Connections Academy students can work with their school counselor to explore and identify the career path that is right for them.

ROTH MKM's Agribusiness Investment Banking Group Sees Success with the Closing of Three M&A Sellside Transactions

Retrieved on: 
Tuesday, April 11, 2023

ROTH MKM (“Roth”), www.roth.com , a relationship-driven investment bank focused on serving growth companies and their investors, is pleased to announce that their agribusiness investment banking group has advised on three sellside transactions in the past nine months.

Key Points: 
  • ROTH MKM (“Roth”), www.roth.com , a relationship-driven investment bank focused on serving growth companies and their investors, is pleased to announce that their agribusiness investment banking group has advised on three sellside transactions in the past nine months.
  • "ROTH MKM has built a dedicated agribusiness effort with investment banking and research resources that exclusively work with entities whose business models are influenced by agriculture and are the disrupters and best-in-class operators in their related fields.
  • Our experience and expertise in this sector position us to provide actionable advice and execute transactions that meet our clients' needs,” said Ivan Saval, Managing Director and Head of ROTH MKM's Agribusiness Investment Banking Group.
  • “Our focus on agtech and agribusiness is driven by the growing demand for sustainable and innovative solutions in the industry.

Bioceres Crop Solutions Completes Merger With Marrone Bio, Creating a Global Leader in Sustainable Agricultural Solutions

Retrieved on: 
Tuesday, July 12, 2022

The completion of this transaction represents an important milestone in our journey, cementing our leadership in the development and commercialization of sustainable agricultural solutions, said Bioceres Chief Executive Officer, Federico Trucco.

Key Points: 
  • The completion of this transaction represents an important milestone in our journey, cementing our leadership in the development and commercialization of sustainable agricultural solutions, said Bioceres Chief Executive Officer, Federico Trucco.
  • Newly issued Bioceres shares will commence trading on the Nasdaq Global Select Market under the symbol BIOX.
  • MBI will continue to operate its existing lines of business and products under the name ProFarm as a wholly owned subsidiary of Bioceres.
  • About Bioceres Crop Solutions Corp.
    Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality.

Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.

Retrieved on: 
Monday, July 11, 2022

At the special meeting, MBIs stockholders approved the adoption of the Merger Agreement and approved on a non-binding advisory basis certain executive compensation that may be paid or become payable in connection with the merger contemplated by the Merger Agreement.

Key Points: 
  • At the special meeting, MBIs stockholders approved the adoption of the Merger Agreement and approved on a non-binding advisory basis certain executive compensation that may be paid or become payable in connection with the merger contemplated by the Merger Agreement.
  • Marrone Bio Innovations, Inc. (NASDAQ: MBII) is a growth-oriented agricultural company leading the movement to environmentally sustainable farming practices through the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition.
  • About Bioceres Crop Solutions Corp.
    Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a fully integrated provider of crop productivity technologies designed to enable the transition of agriculture towards carbon neutrality.
  • To do this, Bioceres solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices.

MARRONE BIO INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Marrone Bio Innovations, Inc. - MBII

Retrieved on: 
Wednesday, May 4, 2022

Kuznicki Law PLLC is investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).

Key Points: 
  • Kuznicki Law PLLC is investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).
  • Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own.
  • If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, contact us toll free at 833-938-0905, via email ( [email protected] ), or visit https://kclasslaw.com/cases/ma/nasdaqcm-mbii/ to learn more.
  • Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship.

MARRONE BIO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marrone Bio Innovations, Inc. - MBII

Retrieved on: 
Wednesday, April 27, 2022

and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).
  • Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time

Retrieved on: 
Wednesday, April 27, 2022

A playback of the call will be available through May 18, 2022.

Key Points: 
  • A playback of the call will be available through May 18, 2022.
  • A webcast will also be available for 30 days on the IR section of the Marrone Bio Innovations website or by clicking here: MBII Q1 2022 Webcast .
  • Our portfolio of 18 products helps customers operate more sustainably while increasing their return on investment.
  • The companys commercial products are sold globally and supported by a robust portfolio of more than 500 issued and pending patents.

Marrone Bio Expands Biological Seed Treatment Collaboration for Row Crops

Retrieved on: 
Thursday, March 24, 2022

Marrone Bio currently provides seed treatment solutions to Corteva for use throughout Europe.

Key Points: 
  • Marrone Bio currently provides seed treatment solutions to Corteva for use throughout Europe.
  • MBI introduced biological seed treatments as a sustainable alternative to control yield-robbing pests in the United States in 2017.
  • Today, more than 30% of MBIs annual revenues come from seed technologies used on approximately 35 million acres of major row crops such as corn, soybeans, wheat, cotton and sunflowers.
  • Expanding our global cooperation with Corteva affirms the strength of the partnership we have developed over the last two years, states Kevin Helash, chief executive officer of Marrone Bio.

MARRONE BIO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Marrone Bio Innovations, Inc. - MBII

Retrieved on: 
Saturday, March 19, 2022

and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX).
  • Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

MARRONE BIO INNOVATIONS ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of MBII and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, March 17, 2022

On March 16, 2022, MBI announced that it had entered into an agreement to merge with Bioceres in a deal valued at approximately $236 million.

Key Points: 
  • On March 16, 2022, MBI announced that it had entered into an agreement to merge with Bioceres in a deal valued at approximately $236 million.
  • Pursuant to the merger agreement, MBI stockholders will receive ordinary shares of Bioceres at a fixed ratio of 0.088.
  • Bragar Eagel & Squire is concerned that MBIs board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.